ARCHIVES

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 21 No. 33 | August 18, 1995

Download PDF Visit The Full Archive

Related Articles

PhRMA’s New Ethics Code Prohibits Trinkets, Dinners; Speaking Fees Still OK.

July 11, 2008

NCI Programs: Advisors Approve Recompetition of Phase II Contracts

July 9, 1999

In Brief: NSABP Selects 193 Institutions For STAR; ACR Names Evens, Ramsey As New Officers

October 9, 1998

Animal Problems May Stop NIC Construction Grant To city Of Hope

September 13, 1985

Weekly Paclitaxel Better Than Every Three Weeks

June 25, 2004

Age Doesn’t Affect Survival After Bone Marrow Transplant

December 26, 2008